Mylan Smart Injection Tracker®
Free
3.1for iPhone
Age Rating
Mylan Smart Injection Tracker® Screenshots
About Mylan Smart Injection Tracker®
Record your injections of Mylan’s Glatiramer Acetate injection with the Mylan Smart Injection Tracker®.
Record where you inject, each time you inject, and use injection reminders and notifications to keep on top of your site rotation plan. At home or away, Mylan Smart Injection Tracker® lets you track your injections.
Mylan Smart Injection Tracker® is designed specifically for use with Mylan’s Glatiramer Acetate Injection.
Features enable you to:
• Set injection reminders and notifications (if you forget to record an injection)
• Track and plan rotation of your injection sites
• Take notes and record questions to discuss with your doctor or nurse
• Customize app settings and features to fit your lifestyle
• Learn best practices with our helpful injection tips
USE
GLATIRAMER ACETATE INJECTION is a prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
IMPORTANT SAFETY INFORMATION
Do not take GLATIRAMER ACETATE INJECTION if you are allergic to glatiramer acetate or mannitol.
Some patients report a short-term reaction right after injecting glatiramer acetate.
This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of
an injection. Call your doctor right away if you have any of these symptoms and do not give yourself more injections until your doctor tells you to.
Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain usually only lasts a few minutes. You may experience more than one such episode, usually
beginning at least one month after starting treatment. Tell your doctor if you experience chest pain.
A permanent indentation under the skin (lipoatrophy and, rarely, death of your skin tissue also referred to as necrosis) at the injection site may occur due to local destruction of fat tissue. Be sure to follow your doctor’s instruction on how to use glatiramer acetate injection and be sure to choose a different injection site each time you use glatiramer acetate injection.
The most common side effects in studies of GLATIRAMER ACETATE INJECTION are redness, pain, swelling, itching, or a lump at the site of injection, rash, shortness of breath, and flushing.
These are not all the possible side effects of GLATIRAMER ACETATE INJECTION. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects that you have while taking GLATIRAMER ACETATE INJECTION.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information, Patient Information Leaflet and Instructions for Use for GLATIRAMER ACETATE INJECTION 20 mg/mL or 40 mg/mL, available at glatirameracetate.com
Mylan Smart Injection Tracker® is a registered trademark of Mylan Pharmaceuticals Inc. Mylan's Glatiramer Acetate Injection logo is a registered trademark of Mylan Pharmaceuticals Inc.
MYLAN and the Mylan logo are registered trademarks of Mylan Inc.
©2020 Mylan N.V. All rights reserved.
GA-2020-0003
Record where you inject, each time you inject, and use injection reminders and notifications to keep on top of your site rotation plan. At home or away, Mylan Smart Injection Tracker® lets you track your injections.
Mylan Smart Injection Tracker® is designed specifically for use with Mylan’s Glatiramer Acetate Injection.
Features enable you to:
• Set injection reminders and notifications (if you forget to record an injection)
• Track and plan rotation of your injection sites
• Take notes and record questions to discuss with your doctor or nurse
• Customize app settings and features to fit your lifestyle
• Learn best practices with our helpful injection tips
USE
GLATIRAMER ACETATE INJECTION is a prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
IMPORTANT SAFETY INFORMATION
Do not take GLATIRAMER ACETATE INJECTION if you are allergic to glatiramer acetate or mannitol.
Some patients report a short-term reaction right after injecting glatiramer acetate.
This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of
an injection. Call your doctor right away if you have any of these symptoms and do not give yourself more injections until your doctor tells you to.
Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain usually only lasts a few minutes. You may experience more than one such episode, usually
beginning at least one month after starting treatment. Tell your doctor if you experience chest pain.
A permanent indentation under the skin (lipoatrophy and, rarely, death of your skin tissue also referred to as necrosis) at the injection site may occur due to local destruction of fat tissue. Be sure to follow your doctor’s instruction on how to use glatiramer acetate injection and be sure to choose a different injection site each time you use glatiramer acetate injection.
The most common side effects in studies of GLATIRAMER ACETATE INJECTION are redness, pain, swelling, itching, or a lump at the site of injection, rash, shortness of breath, and flushing.
These are not all the possible side effects of GLATIRAMER ACETATE INJECTION. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects that you have while taking GLATIRAMER ACETATE INJECTION.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information, Patient Information Leaflet and Instructions for Use for GLATIRAMER ACETATE INJECTION 20 mg/mL or 40 mg/mL, available at glatirameracetate.com
Mylan Smart Injection Tracker® is a registered trademark of Mylan Pharmaceuticals Inc. Mylan's Glatiramer Acetate Injection logo is a registered trademark of Mylan Pharmaceuticals Inc.
MYLAN and the Mylan logo are registered trademarks of Mylan Inc.
©2020 Mylan N.V. All rights reserved.
GA-2020-0003
Show More
What's New in the Latest Version 3.1
Last updated on Jul 24, 2020
Old Versions
Optimized for latest operating systems
Fixed bug associated with adherence storage and time zone
Fixed bug where reminders were sent on 40 mg/mL non-injection days
Updates to logo, terms of use and Product use
Fixed bug associated with adherence storage and time zone
Fixed bug where reminders were sent on 40 mg/mL non-injection days
Updates to logo, terms of use and Product use
Show More
Version History
3.1
Jul 24, 2020
Optimized for latest operating systems
Fixed bug associated with adherence storage and time zone
Fixed bug where reminders were sent on 40 mg/mL non-injection days
Updates to logo, terms of use and Product use
Fixed bug associated with adherence storage and time zone
Fixed bug where reminders were sent on 40 mg/mL non-injection days
Updates to logo, terms of use and Product use
3.0
Jan 30, 2019
Fixed bug associated with 3x weekly dosage.
Updates to Logo, Trademark, Terms Of Use and Important Safety Information
Updates to Logo, Trademark, Terms Of Use and Important Safety Information
2.0
Oct 5, 2017
Performance improvements
1.2
Oct 4, 2017
Initial Release.
1.0
Jul 16, 2014
Mylan Smart Injection Tracker® FAQ
Click here to learn how to download Mylan Smart Injection Tracker® in restricted country or region.
Check the following list to see the minimum requirements of Mylan Smart Injection Tracker®.
iPhone
Mylan Smart Injection Tracker® supports English